| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Modified Organism
Raboral V-RG (vaccine against rabies)
Record information and status
Record ID
100345
Status
Published
Date of creation
2009-08-10 20:55 UTC (manoela.miranda@cbd.int)
Date of last update
2012-06-18 15:25 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-06-18 15:25 UTC (dina.abdelhakim@cbd.int)

Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.

LMO name
Raboral V-RG (vaccine against rabies)
Transformation event
Not available
Developer(s)
Rhône Mérieux
Description
The glygoprotein G from the rabies virus was cloned and expressed into the vaccinia virus strain Copenhagen (tk- phenotype) to produce a vaccine called RABORAL V-RG®.
Recipient Organism or Parental Organisms
The term Recipient organism refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas Parental organisms refers to those that were involved in cross breeding or cell fusion.
Vaccinia virus - Poxvirus, Smallpox vaccine, VACV, VV, Vaccinia
Point of collection or acquisition of the recipient organism
Vaccinia virus Copenhagen (tk- phenotype)strain used
Characteristics of the transformation process
Introduced or modified genetic elements
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
Rabies Glycoprotein - Rabies virus - Rabies virus
Resistance to diseases and pests - Viruses
LMO characteristics
Modified traits
Common use(s)
  • Vaccine
Additional Information
Other relevant website address or attached documents